ISR Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (17 Feb 2023 @ 16:00):

Stats
Today's Volume	145 041
Average Volume	280 832
Market Cap	0.00
EPS	$-0.0369 ( 2023-09-29 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0
ATR14	$0.0210 (5.47%)

Insider Trading

Date	Person	Action	Amount	type
2023-12-21	Williamson Robert F Iii	Buy	3 663	Common Stock
2023-12-18	Hunt Jonathan Robert	Buy	125 000	Common Stock
2023-12-19	Williamson Robert F Iii	Buy	13 680	Common Stock
2023-12-18	Williamson Robert F Iii	Buy	10 000	Common Stock
2023-12-19	Puhlmann Markus	Buy	400 000	Common Stock

INSIDER POWER
38.49
Last 96 transactions
Buy: 20 677 783 \| Sell: 10 913 801

Volume Correlation

Long: 0.03 (neutral)

Short: -0.87 (strong negative)

Signal:(58.654) Neutral

IsoRay Inc Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

IsoRay Inc Correlation - Currency/Commodity

-0.27
( neutral )

-0.26
( neutral )

0.00
( neutral )

-0.32
( neutral )

-0.03
( neutral )

0.40
( neutral )

IsoRay Inc Financials

Annual	2023
Revenue:	$1.43M
Gross Profit:	$1.43M (100.00 %)
EPS:	$-173.77

FY	2023
Revenue:	$1.43M
Gross Profit:	$1.43M (100.00 %)
EPS:	$-173.77

FY	2022
Revenue:	$10.80M
Gross Profit:	$4.62M (42.76 %)
EPS:	$-0.0504

FY	2021
Revenue:	$10.05M
Gross Profit:	$5.12M (50.94 %)
EPS:	$-0.0300

Financial Reports:

No articles found.

IsoRay Inc

Isoray, Inc., through its subsidiary, IsoRay Medical, Inc., develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers. It sells its products to facilities or physician practices that utilize various surgical facilities. Isoray, Inc. was founded in 1998 and is based in Richland, Washington.